SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-352475
Filing Date
2012-08-13
Accepted
2012-08-13 16:24:10
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d358408d10q.htm 10-Q 553311
2 EX-31.1 d358408dex311.htm EX-31.1 6332
3 EX-31.2 d358408dex312.htm EX-31.2 6457
4 EX-32.1 d358408dex321.htm EX-32.1 4845
  Complete submission text file 0001193125-12-352475.txt   2808038

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tspt-20120630.xml EX-101.INS 387356
6 XBRL TAXONOMY EXTENSION SCHEMA tspt-20120630.xsd EX-101.SCH 23483
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tspt-20120630_cal.xml EX-101.CAL 30354
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tspt-20120630_def.xml EX-101.DEF 59812
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tspt-20120630_lab.xml EX-101.LAB 168612
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tspt-20120630_pre.xml EX-101.PRE 122983
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51967 | Film No.: 121027939
SIC: 2834 Pharmaceutical Preparations